← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2013Last known activity
Nov 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 9 trials)
Phase 4 (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05520112CollaboratorPhase 1/Phase 2Nov 1, 2022
- NCT05520125CollaboratorPhase 1/Phase 2Nov 1, 2022
- NCT04432467CollaboratorPhase 1/Phase 2Oct 1, 2020
- NCT04446897CollaboratorPhase 1/Phase 2Aug 3, 2020
- NCT04434794CollaboratorPhase 1/Phase 2Jan 1, 2018
- NCT04146519Lead sponsorPhase 2Jul 1, 2017
- NCT03130374CollaboratorPhase 1/Phase 2Jan 3, 2017
- NCT04485962CollaboratorPhase 1/Phase 2Jan 1, 2017
- NCT02140073Overall official - principal investigatorPhase 4Dec 1, 2013
- NCT02140073Lead sponsorPhase 4Dec 1, 2013
Details
- Last known activity
- Nov 1, 2022